NasdaqGS - Nasdaq Real Time Price USD

Alignment Healthcare, Inc. (ALHC)

Compare
11.47 +0.35 (+3.15%)
At close: September 27 at 4:00 PM EDT
11.50 +0.03 (+0.26%)
After hours: September 27 at 5:41 PM EDT
Loading Chart for ALHC
DELL
  • Previous Close 11.12
  • Open 11.21
  • Bid 11.44 x 200
  • Ask 11.47 x 200
  • Day's Range 11.15 - 11.64
  • 52 Week Range 4.46 - 12.36
  • Volume 632,490
  • Avg. Volume 1,037,891
  • Market Cap (intraday) 2.194B
  • Beta (5Y Monthly) 1.44
  • PE Ratio (TTM) --
  • EPS (TTM) -0.80
  • Earnings Date Oct 31, 2024 - Nov 4, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 10.15

Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

www.alignmenthealth.com

1,536

Full Time Employees

December 31

Fiscal Year Ends

Recent News: ALHC

View More

Performance Overview: ALHC

Trailing total returns as of 9/27/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ALHC
33.22%
S&P 500
20.30%

1-Year Return

ALHC
67.20%
S&P 500
34.27%

3-Year Return

ALHC
31.89%
S&P 500
28.79%

5-Year Return

ALHC
39.79%
S&P 500
44.37%

Compare To: ALHC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ALHC

View More

Valuation Measures

Annual
As of 9/27/2024
  • Market Cap

    2.13B

  • Enterprise Value

    1.98B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.97

  • Price/Book (mrq)

    17.74

  • Enterprise Value/Revenue

    0.92

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -6.84%

  • Return on Assets (ttm)

    -10.71%

  • Return on Equity (ttm)

    -91.03%

  • Revenue (ttm)

    2.23B

  • Net Income Avi to Common (ttm)

    -152.79M

  • Diluted EPS (ttm)

    -0.80

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    363.71M

  • Total Debt/Equity (mrq)

    176.22%

  • Levered Free Cash Flow (ttm)

    -48.46M

Research Analysis: ALHC

View More

Company Insights: ALHC

Research Reports: ALHC

View More

People Also Watch